Actively Recruiting
Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery
Led by AC Camargo Cancer Center · Updated on 2025-12-08
164
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The treatment of colorectal cancer, in the absence of metastases, is primarily based on surgical removal. Colorectal surgery, which involves resecting part of the intestine and restoring intestinal continuity, carries a risk of complications. This study aims to evaluate whether oral supplementation with a postbiotic at a dose of 900 mg for 7 days prior to surgery reduces the rate of postoperative complications.
CONDITIONS
Official Title
Use of Preoperative Postbiotic Supplementation in Colorectal Cancer Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with malignant neoplasm of the large intestine, specifically adenocarcinoma
- Age over 18 years
- Both males and females
- Agree to participate and sign informed consent
You will not qualify if you...
- Emergency or urgent surgeries
- Cytoreductive surgeries with intraoperative intraperitoneal chemotherapy
- Extended surgeries for recurrent tumors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
A.C.Camargo Cancer Center
São Paulo, São Paulo, Brazil, 01509-010
Actively Recruiting
Research Team
S
Samuel A Junior, MD, PhD
CONTACT
B
Bruna E Catin Kupper, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here